HCV In At Risk Populations: Who Can be Treated and How? Anthony D. MartinezRobert G. Gish Hepatitis C: Complex Clinical Issues (S Harrison and N Reau, Section Editors) 04 January 2012 Pages: 1 - 9
Acute HCV: Will IL28B Testing Change the Paradigm? Hans L. Tillmann Hepatitis C: Complex Clinical Issues (S Harrison and N Reau, Section Editors) 08 January 2012 Pages: 10 - 14
IL28B: Implications for Clinical Practice Alison JazwinskiAndrew Muir Hepatitis C: Complex Clinical Issues (S Harrison and N Reau, Section Editors) 06 January 2012 Pages: 15 - 22
Boceprevir versus Telaprevir: A New Era of Directly Acting Antiviral Therapy Joseph AhnSteven L. Flamm Hepatitis C: Complex Clinical Issues (S Harrison and N Reau, Section Editors) 13 January 2012 Pages: 23 - 33
HCV and Chemotherapy: Does Infection Change Management? Jacqueline G. O’LearyGary L. Davis Hepatitis C: Complex Clinical Issues (S Harrison and N Reau, Section Editors) 21 December 2011 Pages: 34 - 40
The Role of Iron in Hepatitis C Infection Tusar K. DesaiJared BortmanHerbert Bonkovsky Hepatitis C: Complex Clinical Issues (S Harrison and N Reau, Section Editors) 13 January 2012 Pages: 41 - 47
HCV Therapy in 2011: Development of New Treatment Paradigms for Naïve and Non-Responder Patients Masood MansourPaul J. Pockros Hepatitis C: Complex Clinical Issues (S Harrison and N Reau, Section Editors) 12 January 2012 Pages: 48 - 54